Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Conflicts of interest are eroding trust in U.S. health agencies

Martha Rosenberg
Policy
May 8, 2025
Share
Tweet
Share

Why has faith in government health agencies never been lower? Because conflicts of interest (COIs) have never been higher.

At the FDA, concerns about drugmakers “buying” drug approvals go back to passage of the Prescription Drug User Fee Act (PDUFA) in 1992. Since then, the many doctors with research and speaker grants, drug stocks, and past employment with drugmakers heighten concerns. Worse, many major drug trials that claim to show “benefits,” like those with GLP-1 drugs today (repeated *ipso facto* by mainstream media), are funded by the tested drugs’ makers. Did anyone expect the tested drug would fail?

Conflicted FDA commissioners

In March of 2017, President Trump chose Dr. Scott Gottlieb to serve as FDA Commissioner. Dr. Gottlieb “has been a frequent consultant to drug companies, serving on advisory boards for large pharmaceutical companies like GlaxoSmithKline and Daiichi Sankyo,” and “paid millions by industry,” wrote the New York Times.

But Dr. Robert Califf, the FDA commissioner under both Presidents Barack Obama and Joe Biden, made Dr. Gottlieb look like an amateur. “Many of us consult with the pharmaceutical industry, which I think is a very good thing,” said Dr. Califf on PBS in 2004. His financial links to drugmakers are astounding.

Dr. Margaret Hamburg, the FDA commissioner who preceded Dr. Califf, also came under the ethical microscope after she left office in 2015. Her alleged COIs were especially ironic in light of her lamentation in 2011 that the government could not find enough experts not funded by drugmakers for advisory committees.

Industry funds the CDC Foundation

Few are aware of the existence of the CDC Foundation, a separate, nonprofit organization, established by Congress in 1992 to seek private-sector donations and public-private partnerships.

According to Netsuite, Wells Fargo, Kaiser Permanente, 3M, Bayer, and the Robert Wood Johnson Foundation are among donors. In 2018, members of the House of Representatives appropriations subcommittee questioned the CDC and NIH Foundations’ anonymous donors.

Concerns about CDC COIs came to a head in 2017 when the newly appointed director, Dr. Brenda Fitzgerald, was found to have accepted $1 million from Coca-Cola while serving as health commissioner of Georgia. (The following year, planned NIH studies on alcohol and opioid effects were scrapped because of industry funding.)

Other conflicted CDC directors

Dr. Fitzgerald was forced to resign from the CDC after only six months because of tobacco stocks she had bought. Before her, CDC Director Dr. Tom Frieden was also tarnished with a COI. During a 2015 influenza outbreak, Dr. Frieden told reporters that the CDC had “compelling evidence” that Tamiflu (oseltamivir) worked for flu, his financial links to its maker notwithstanding. The CDC was simultaneously conducting an awareness campaign with Tamiflu recommendations.

And who can forget how Dr. Julie Gerberding, who preceded Dr. Frieden as CDC director, led efforts against the H5N1 flu before becoming head of Merck Vaccines the same year she left the government?

More recently, Dr. Robert Redfield, CDC director until 2021, was accused of misrepresenting experimental drug data he published.

ADVERTISEMENT

Conflict temptations

There are three pharma lobbyists for every Congress member, and more than two-thirds of Congress members cashed a pharma campaign check in 2020. Medical journals now unapologetically publish “research” funded by drugmakers that they once would have eschewed. Are they replacing the ads they lost to TV, which has become a main media revenue stream? It has never been more lucrative to be financially linked to Big Pharma––or more dangerous for the trusting patient.

Martha Rosenberg is a health reporter and the author of Big Food, Big Pharma, Big Lies and Born With a Junk Food Deficiency.  

Prev

Why the words doctors use matter more than they think

May 8, 2025 Kevin 0
…
Next

From rejection to resilience: my journey through emergency medicine residency

May 8, 2025 Kevin 0
…

Tagged as: Public Health & Policy

Post navigation

< Previous Post
Why the words doctors use matter more than they think
Next Post >
From rejection to resilience: my journey through emergency medicine residency

ADVERTISEMENT

More by Martha Rosenberg

  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • How drug companies turned “depression” into a billion-dollar industry

    Martha Rosenberg
  • The untold truths behind overdiagnosis and why it matters to your health

    Martha Rosenberg

Related Posts

  • Clinicians unite for health care reform

    Leslie Gregory, PA-C
  • Global aspirations for value-based health care

    Paul Pender, MD
  • Melting the iron triangle: Prioritizing health equity in dynamic, innovative health care landscapes

    Nina Cloven, MHA
  • States have the power to influence health care

    Ruhi Saldanha
  • A health economist acknowledges how financing experiments failed our health system

    James G. Kahn, MD, MPH
  • Are negative news cycles and social media injurious to our health?

    Rabia Jalal, MD

More in Policy

  • How the One Big Beautiful Bill could reshape your medical career

    Kara Pepper, MD
  • Why the U.S. Preventive Services Task Force is essential to saving lives

    J. Leonard Lichtenfeld, MD
  • Brooklyn hepatitis C cluster reveals hidden dangers in outpatient clinics

    Don Weiss, MD, MPH
  • Why nearly 800 U.S. hospitals are at risk of shutting down

    Harry Severance, MD
  • Innovation is moving too fast for health care workers to catch up

    Tiffiny Black, DM, MPA, MBA
  • How pediatricians can address the health problems raised in the MAHA child health report

    Joseph Barrocas, MD
  • Most Popular

  • Past Week

    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • Why physician strikes are a form of hospice

      Patrick Hudson, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Who are you outside of the white coat?

      Annia Raja, PhD | Conditions
    • How hospitals can prepare for CMS’s new patient safety rule

      Kim Adelman, PhD | Conditions
    • Physician practice ownership: risks, rewards, and reality

      Paul Morton, CFP | Finance
    • How peer support can save physician lives [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why AI in health care needs the same scrutiny as chemotherapy

      Rafael Rolon Rivera, MD | Tech
    • The humanity we bring: a call to hold space in medicine

      Kathleen Muldoon, PhD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • Why physician strikes are a form of hospice

      Patrick Hudson, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Who are you outside of the white coat?

      Annia Raja, PhD | Conditions
    • How hospitals can prepare for CMS’s new patient safety rule

      Kim Adelman, PhD | Conditions
    • Physician practice ownership: risks, rewards, and reality

      Paul Morton, CFP | Finance
    • How peer support can save physician lives [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why AI in health care needs the same scrutiny as chemotherapy

      Rafael Rolon Rivera, MD | Tech
    • The humanity we bring: a call to hold space in medicine

      Kathleen Muldoon, PhD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...